비뇨의학 Urology DigestISSN:2713-7910(Print) 2733-5453(Online)대한비뇨의학과의사회

Mader S et al., Liquid Biopsy: Current Status and Future Perspectives, Oncol Res Treat, 2017 10.1159/00047801828693023

Poulet G et al., Liquid Biopsy: General Concepts, Acta Cytol, 2019 10.1159/00049933731091522

Allott EH et al., Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification, Breast Cancer Res, 2016 10.1186/s13058-016-0725-127349894PMC4924300

Chen M et al., Next-generation sequencing in liquid biopsy: cancer screening and early detection, Hum Genomics, 2019 10.1186/s40246-019-0220-831370908PMC6669976

Siegel RL et al., Cancer statistics, CA Cancer J Clin, 2020 10.3322/caac.2159031912902

Vickers AJ et al., A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden. BMC Med, 2008 10.1186/1741-7015-6-1918611265PMC2474851

Ferro M et al., Biomarkers in localized prostate cancer, Future Oncology, 2016 10.2217/fon.15.31826768791PMC5549774

Vasudev NS et al., Renal cancer biomarkers: the promise of personalized care, BMC Medicine, 2012 10.1186/1741-7015-10-11223016578PMC3521191

Larroquette M et al., Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives, Cancer Treat Rev, 2021 10.1016/j.ctrv.2021.10220733906023

Xu Y et al., Urinary Exosomes Diagnosis of Urological Tumors: A Systematic Review and Meta-Analysis, Front Oncol, 2021 10.3389/fonc.2021.73458734568070PMC8462303

Haga N et al., Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma, Ann Surg Oncol, 2020 10.1097/JU.0000000000000926.012

Palmela Leitao T et al., Circulating tumor cell detection methods in renal cell carcinoma: A systematic review, Crit Rev Oncol Hematol, 2021 10.1016/j.critrevonc.2021.10333133862248

Kouba E et al., Liquid biopsy in the clinical management of bladder cancer: current status and future developments, Expert Review of Molecular Diagnostics, 2019 10.1080/14737159.2019.168028431608720

Kawamura Y et al., Extracellular vesicles as trans-genomic agents: Emerging roles in disease and evolution, Cancer Science, 2017 10.1111/cas.1322228256033PMC5448650

Casanova-Salas I et al., Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer, Eur Urol, 2021 10.1016/j.eururo.2020.12.03733422353PMC8941682

De Bono JS et al., Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration- Resistant Prostate Cancer, Clinical Cancer Research, 2008 10.1158/1078-0432.CCR-08-087218829513

Aghamir SMK et al., Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors, Epigenet Insights, 2020 10.1177/251686572090405232166219PMC7050026

Voss MH et al., Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy, Clin Cancer Res, 2014 10.1158/1078-0432.CCR-13-234524622468PMC4140619

Cimadamore A et al., Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy, Cancers, 2019 10.20944/preprints201812.0066.v1

Hayashi Y et al., Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer, Front Oncol, 2020 10.3389/fonc.2020.0075532509577PMC7250242

Herranz R et al., Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review, Cancers (Basel), 2021 10.3390/cancers1306144833810039PMC8005001

Hawkey NM et al., Liquid Biopsy: It's the Bloody Truth!, Clinical Cancer Research, 2021 10.1158/1078-0432.CCR-21-053133795259PMC8172457

Wang Y et al., Liquid biopsy in prostate cancer: current status and future challenges of clinical application, Aging Male, 2021 10.1080/13685538.2021.194408534850655

Merchant ML et al., Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery, Nat Rev Nephrol, 2017 10.1038/nrneph.2017.14829081510PMC5941934

Lokeshwar VB et al., Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol, 2001 10.1097/00005392-200104000-0000311257640

Wang L et al., CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p, Mol Cancer, 2019 10.1186/s12943-019-0997-z30975145PMC6458839

Zhang J et al., Distinct non-invasive evaluation values of tumor-derived cell-free microRNAs, circulating microvesicles and exosomal microRNAs after renal carcinoma cryoablation, Biochem Biophys Res Commun, 2018 10.1016/j.bbrc.2018.07.03730017193

Xu HY et al., CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM‑CSF and IL‑12, enhance the anti‑renal cortical adenocarcinoma effect, Oncology Reports, 2019 10.3892/or.2019.7208

Thongboonkerd V. Roles for Exosome in Various Kidney Diseases and Disorders, Front Pharmacol, 2019 10.3389/fphar.2019.0165532082158PMC7005210

Zhan Y et al., Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer, Molecular Cancer, 2018 10.1186/s12943-018-0893-y30268126PMC6162963

Zhang S et al., Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer, Journal of Cellular and Molecular Medicine, 2019

Geng H et al., Exosomes in bladder cancer: novel biomarkers and targets, J Zhejiang Univ Sci B, 2021 10.1631/jzus.B200071133973417PMC8110466

Wang J et al., Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer, Crit Rev Oncol Hematol, 2020 10.1016/j.critrevonc.2019.10286031874447

Franceschini T et al., Liquid biopsies in urological cancers: what we need to know before starting using them, Expert Rev Mol Diagn, 2020 10.1080/14737159.2019.166550831509027

El Bali L et al., Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies, J Biomol Tech, 2014 10.7171/jbt.14-2504-00225365790PMC4189459